Literature DB >> 27261681

Severe, Highly Active, or Aggressive Multiple Sclerosis.

Mark S Freedman, Carolina A Rush.   

Abstract

PURPOSE OF REVIEW: Despite the efficacy of current therapies for relapsing forms of multiple sclerosis (MS), there remains a group of patients whose disease fails to respond and warrants a different approach to treatment. This article reviews this form of aggressive MS and proposes a definition and new treatment algorithm. Failing to recognize aggressive MS and initiate more effective therapy will result in a lost opportunity to effectively treat the disease. RECENT
FINDINGS: Natural history studies, together with the results of contemporary clinical trials, help to identify and profile a subset of patients with relapsing MS who have a much poorer prognosis and for whom conventional treatment tends to fail. Therapies that have shown success in the treatment of this patient group with aggressive MS are reviewed and discussed.
SUMMARY: It is imperative to recognize aggressive MS to effectively treat it before patients progress. Recognizing aggressive MS as early as possible is the key to successful implementation of a proposed algorithm.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27261681     DOI: 10.1212/CON.0000000000000331

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  6 in total

Review 1.  Current concepts in multiple sclerosis therapy.

Authors:  Leslie Sedal; Antony Winkel; Joshua Laing; Lai Yin Law; Elizabeth McDonald
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-09-28

Review 2.  Treatment of relapsing multiple sclerosis - recommendations of the Croatian Neurological Society.

Authors:  Mario Habek; Ivan Adamec; Barbara Barun; Vanja Bašić Kes; Andrijana Bogoje Raspopović; Klaudia Duka Glavor; Tereza Gabelić; Tihana Grzinčić; Mirjam Jukić; Miljenka-Jelena Jurašić; Spomenka Kiđemet-Piskač; Milica Komšo; Julija Rimac; Ines Lazibat; Branka Lukić; Anita Marčinko; Meri Matijaca; Marija Ratković; Lidija Šapina; Vladimira Vuletić; Tea Mirošević Zubonja; Magdalena Krbot Skorić
Journal:  Croat Med J       Date:  2022-08-31       Impact factor: 2.415

3.  Iron deposition in multiple sclerosis: overall load or distribution alteration?

Authors:  Eman Hamdy; Aya Abdel Galeel; Ismail Ramadan; Dina Gaber; Haytham Mustafa; Jaidaa Mekky
Journal:  Eur Radiol Exp       Date:  2022-09-08

4.  Treatment patterns and comorbid burden of patients newly diagnosed with multiple sclerosis in the United States.

Authors:  David M Kern; M Soledad Cepeda
Journal:  BMC Neurol       Date:  2020-08-11       Impact factor: 2.474

5.  Aggressive multiple sclerosis: a matter of measurement and timing.

Authors:  David Ellenberger; Peter Flachenecker; Firas Fneish; Niklas Frahm; Kerstin Hellwig; Friedemann Paul; Alexander Stahmann; Clemens Warnke; Paulus S Rommer; Uwe K Zettl
Journal:  Brain       Date:  2020-12-05       Impact factor: 13.501

Review 6.  Predictive MRI Biomarkers in MS-A Critical Review.

Authors:  Vlad Eugen Tiu; Iulian Enache; Cristina Aura Panea; Cristina Tiu; Bogdan Ovidiu Popescu
Journal:  Medicina (Kaunas)       Date:  2022-03-03       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.